Clinical Validation of PROPECG-TMT
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Screening for coronary artery revascularization based on TMT-ECG
- Registration Number
- NCT06624852
- Lead Sponsor
- Yonsei University
- Brief Summary
This clinical validation evaluates the performances of physicians with and without learning with PROPECG-TMT assistance for screening coronary artery revascularization on TMT-ECG.
There are two endpoints used to evaluate performances: Accuracy (primary endpoints with pair specificity/sensitivity, and PPV/NPV), and time needed for screening (secondary endpoints with time measurements in all cases).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- TMT ECG exams adjudicated as equivocal cases
Exclusion Criteria
- Exams not converting to median beat ECG
- Exams not containing interpretable exercise
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Performances with AI assistance Screening for coronary artery revascularization based on TMT-ECG Performances of screening coronary artery revascularization with PROPECG-TMT Performances without AI assistance Screening for coronary artery revascularization based on TMT-ECG Performances of screening coronary artery revascularization without PROPECG-TMT
- Primary Outcome Measures
Name Time Method measurement of screening performances 1 month calculation of sensitivity, specificity, NPV, PPV
- Secondary Outcome Measures
Name Time Method Time needed for screening all cases 1 month measurement of the time and comparison between the two cohorts
Trial Locations
- Locations (1)
Department of Biomedicine Systems Informatics, Yonsei University College of Medicine
🇰🇷Seoul, Korea, Republic of